IMUX
Immunic·NASDAQ
--
--(--)
--
--(--)
IMUX fundamentals
Immunic (IMUX) released its earnings on Aug 7, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.2 (YoY +4.76%), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-0.2
+4.76%
Report date
Aug 7, 2025
Earnings Call
6:30 AM on Aug 7, 2025
Meeting link.EPS
Actual | -0.79 | -0.9 | -0.7 | -0.42 | -1.63 | -0.82 | -0.76 | -0.72 | -0.74 | -0.72 | -0.69 | -1.63 | -0.58 | -0.54 | -0.51 | -0.48 | -0.3 | -0.21 | -0.24 | -0.25 | -0.25 | -0.2 | |||||||||
Forecast | -0.955 | -0.772 | -0.6371 | -0.682 | -0.695 | -0.6838 | -0.805 | -0.7663 | -0.8086 | -0.732 | -0.67 | -0.7325 | -0.5175 | -0.525 | -0.5475 | -0.5125 | -0.26 | -0.2325 | -0.2184 | -0.235 | -0.24 | -0.1578 | |||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +17.28% | -16.58% | -9.87% | +38.42% | -134.53% | -19.92% | +5.59% | +6.04% | +8.48% | +1.64% | -2.99% | -122.53% | -12.08% | -2.86% | +6.85% | +6.34% | -15.38% | +9.68% | -9.89% | -6.38% | -4.17% | -26.74% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.00K | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -100.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What factors drove the changes in Immunic's revenue and profit?What is the market's earnings forecast for Immunic next quarter?What were the key takeaways from Immunic's earnings call?What guidance did Immunic's management provide for the next earnings period?Did Immunic beat or miss consensus estimates last quarter?What is Immunic's gross profit margin?What does Immunic do and what are its main business segments?What is the revenue and EPS growth rate for Immunic year over year?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
